Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Pilot Phase II Multi Center Study of Gemcitabine and Nab-paclitaxel (Abraxane) as Preoperative Therapy for Potentially Operable Pancreatic Cancer

NCT01298011 is registered in ClinicalTrials.gov with Pancreatic Cancer Research Team as lead sponsor.

NCT NCT01298011
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01298011 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Pilot Phase II Multi Center Study of Gemcitabine and Nab-paclitaxel (Abraxane) as Preoperative Therapy for Potentially Operable Pancreatic Cancer
Lead sponsor
Pancreatic Cancer Research Team
Phase
Phase 2
Overall status
Completed
Start date
May 31, 2011
Completion date
May 31, 2015
Enrollment
25 (actual)
Sites
4

Conditions

As the registry lists them; a condition with its own page is linked.

resectable pancreatic cancer